Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6

Epidemiology and Infection

Volumn 122, Issue 1, 1999, Pages 41-49

  Connolly, M ^a   Noah, N ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; EPIDEMIOLOGICAL DATA; EUROPE; FATALITY; HUMAN; INFANT; LABORATORY; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEWBORN; SEROTYPE; TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; ENDEMIC DISEASES; EUROPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; NEISSERIA MENINGITIDIS; POPULATION SURVEILLANCE; SEASONS; SEROTYPING;

EID: 0033000992     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268898001848     Document Type: Article

References (17)

1. Lystad A, Aasen S. The epidemiology of meningococcal disease in Norway 1975-1991. NIPH Ann 1991; 14: 57-66.
2. Stuart JM, Cartwright KAV, Dawson JA, Rickard J, Noah N. Risk factors for meningococcal disease: a case control study in south west England. Commun Med 1988; 10: 139-46.
3. Platonov AE, Koroleva IS, Chernyshova TM, Chistyakova GG. Outbreak of group A disease in Moscow. In: European Surveillance of Bacterial Meningitis 1995. London: King's College, 1996: 38-9.
4. Krizová P, Musílek M. Changing epidemiology of meningococcal invasive disease in the Czech Republic. Centr Eur J Publ Hlth 1995; 3: 189-94.
5. Riordan T. A college outbreak of group C meningococcal infection: how widely should investigation and prophylaxis extend? CDR 1997; 7: R5-9.
6. Kaczmarski EB. Meningococcal disease in England and Wales: 1995. CDR 1997; 7: R55-9.
7. Anon. Meningococcal disease in England and Wales. Outbreak due to Neisseria meningitidis serogroup C 2b. CDR 1996; 6: 17.
8. Hansen E. Meningococcal outbreak in a residential college. Epi-news (Denmark) 1996; 44: 1.
9. Velimirovic B. Why we don't know: an incomplete system. In: Greco D, ed. Infectious diseases in Europe. WHO 1984: 35-67.
10. Ramsay M, Kaczmarski E, Rush M, Mallard R, Farrington P, White J. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. CDR 1997; 7: R49-54.
11. Noah N. Transmissible agents. In: Holland WW, Detels R, Knox G, eds. The Oxford textbook of public health, 3rd ed, vol 2. Oxford: Oxford Medical Publications, 1997: 929-49.
12. Djupcsland PG, Bjune G, Høiby EA, Grønnesby JK, Mundal R. Serogroup B meningococcal disease in the Norwegian armed forces. Eur J Pub Hlth 1997; 7: 261-6.
13. Bjune G, Høiby EA, Grønnesby JK, et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991; 338: 1093-6.
14. Iversen BG, Aavitsland P. Meningococcal disease in Norway 1992-1995. Epidemiology and fatality. Scand J Infect Dis 1996; 28: 253-9.
15. Fogarty J. Trends in serogroup C meningococcal disease in the Republic of Ireland. Euro Surv 1997; 2: 75-6.
16. Peltola H, Kataja JM, Mäkelä PH. Shift in age-distribution of meningococcal disease as predictor of an epidemic. Lancet 1982; ii: 595-7.
17. Hubert B, Caugant DA. Recent changes in meningococcal disease in Europe. Euro Surv 1997; 2: 69-71.